SCHEMBL3933848

SCHEMBL3933848

O=Cc1ccc(-c2ccccc2)c(O)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.57
PTGS2 P35354 1/20 0.57
RAB9A P51151 1/20 0.57
ALOX5 P09917 1/20 0.55
BACE1 P56817 2/20 0.52
ALDH1A1 P00352 5/20 0.50
HPGD P15428 2/20 0.50
BCL2L1 Q07817 1/20 0.50
HSD17B10 Q99714 1/20 0.50
AOX1 Q06278 1/20 0.47
PELI1 Q96FA3 1/20 0.46
CYP2A6 P11509 1/20 0.44
TRIM24 O15164 2/20 0.43
TRIM33 Q9UPN9 2/20 0.43
ALDH5A1 P51649 3/20 0.43
ABAT P80404 3/20 0.43
TDP1 Q9NUW8 1/20 0.43
EGFR P00533 1/20 0.42
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9763217 0.86 PELI1 (0.62) KDM4EPTGS2RAB9AALOX5BACE1
SCHEMBL31194720 0.86 PELI1 (0.62) KDM4EPTGS2RAB9AALOX5BACE1
SCHEMBL35967 0.83 ALDH1A1 (0.48) KDM4EPTGS2RAB9AALOX5BACE1
SCHEMBL25068953 0.83 ADORA3 (0.51) KDM4EPTGS2RAB9AALOX5BACE1
SCHEMBL6744610 0.81 PTPN1 (0.49) KDM4EPTGS2RAB9AALOX5BACE1
SCHEMBL29818628 0.80 ALDH1A1 (0.46) KDM4EPTGS2RAB9ABACE1ALDH1A1
SCHEMBL5490742 0.80 ALDH1A1 (0.50) KDM4EALDH1A1PELI1CYP2A6TRIM24
SCHEMBL29671482 0.80 ALDH1A1 (0.50) KDM4EALDH1A1PELI1CYP2A6TRIM24
SCHEMBL17422065 0.80 ALDH1A1 (0.46) KDM4EPTGS2RAB9ABACE1ALDH1A1
2-Phenylphenol SCHEMBL28116733 0.80 ALDH1A1 (0.68) ALOX5BACE1ALDH1A1HPGDBCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116621878-A Phosphor, long-life room-temperature phosphorescent material for light-driven phosphorescent growth and application 重庆理工大学 2023-08-22 CN claimed
CN-113621137-B Preparation method of cyclophosphazenitrile polyimine vitrimer and application of same in preparation of epoxy resin and polyurethane material 北京化工大学 2022-10-18 CN claimed
CN-1646478-A 3-aminophenol derivatives substituted in the 2-position and colorants comprising the same P & G CLAIROL INC (US) 2005-07-27 CN claimed
CN-118978924-A Polymerizable self-assembled vertical orientation layer and preparation method and application thereof 北京科技大学 2024-11-19 CN disclosed
CN-113754589-B Compositions, methods, and systems for synthesizing and using contrast agents 蓝瑟斯医学影像公司 2024-09-27 CN disclosed
CN-116621878-A Phosphor, long-life room-temperature phosphorescent material for light-driven phosphorescent growth and application 重庆理工大学 2023-08-22 CN disclosed
CN-113621137-B Preparation method of cyclophosphazenitrile polyimine vitrimer and application of same in preparation of epoxy resin and polyurethane material 北京化工大学 2022-10-18 CN disclosed
CN-111094300-B Benzo-heteroaryl derivative, preparation method and application thereof in medicine 江苏恒瑞医药股份有限公司 2022-09-16 CN disclosed
CN-104059082-A Nitroimidazole heterocyclic compound and application of nitroimidazole heterocyclic compound in preparation of medicine for treating tuberculosis METABOMICS INC 2014-09-24 CN disclosed
EP-1698635-B1 BENZIMIDAZOLE DERIVATIVES AND MEDICAL USES THEREOF KISSEI PHARMACEUTICAL (JP) 2011-12-14 EP disclosed
US-7547680-B2 Benzimidazole derivatives and medical uses thereof KISSEI PHARMACEUTICALS, CO., LTD. (JP) 2009-06-16 US disclosed
US-20080038242-A1 Benzimidazole derivatives and medical uses thereof KISSEI PHARMACEUTICAL CO., LTD. (JP) 2008-02-14 US disclosed
EP-1698635-A1 BENZIMIDAZOLE DERIVATIVES AND MEDICAL USES THEREOF Kissei Pharmaceutical Co., Ltd. (JP) 2006-09-06 EP disclosed
CN-1784379-A Hydroxy-biphenyl-carbaldehyde oxime derivatives and their use as estrogenic agents WYETH CORP (US) 2006-06-07 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080038242-A1 Benzimidazole derivatives and medical uses thereof SLCO1B3, SLCO2A1, SLCO2B1 KDM4E 2804/4885PTGS2 2556/4885RAB9A 3021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.